Mark Ensor - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mark Ensor

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studiesFrancesco Izzo, Paolo Marra, Gerardo Beneduce, et al.

Journal of Gastroenterology and Hepatology|January 5, 2007

Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesisFrancesco Izzo, Maurizio Montella, Antonio Pio Orlando, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studiesPaolo A Ascierto, Stefania Scala, Giuseppe Castello, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studiesFrancesco Izzo, Paolo Marra, Gerardo Beneduce, et al.

Journal of Gastroenterology and Hepatology|January 5, 2007

Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesisFrancesco Izzo, Maurizio Montella, Antonio Pio Orlando, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studiesPaolo A Ascierto, Stefania Scala, Giuseppe Castello, et al.

Pageof 4